2022 Q3 Form 10-Q Financial Statement

#000156459022028497 Filed on August 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $20.94M $20.07M $22.68M
YoY Change 73.08% 103.98% 78.62%
Cost Of Revenue $24.61M $17.42M $16.59M
YoY Change 51.58% -13.27% 10.23%
Gross Profit $19.27M $18.40M $9.241M
YoY Change 85.33% 117.47% -24.56%
Gross Profit Margin 92.03% 91.67% 40.75%
Selling, General & Admin $12.92M $12.27M $8.865M
YoY Change 133.45% 139.7% 87.82%
% of Gross Profit 67.08% 66.68% 95.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.727M $1.856M $3.508M
YoY Change -43.43% -71.4% 46.17%
% of Gross Profit 8.96% 10.09% 37.96%
Operating Expenses $15.78M $13.05M $7.215M
YoY Change 147.0% -363.12% -1322.88%
Operating Profit $3.486M $5.347M $2.026M
YoY Change -13.0% -60.16% -84.22%
Interest Expense $22.94M $15.75M $14.91M
YoY Change 57.83% -15.81% 8.62%
% of Operating Profit 658.03% 294.46% 735.78%
Other Income/Expense, Net $2.000M $175.0K $338.0K
YoY Change -122.38% -20.09% -69.08%
Pretax Income $5.486M $5.522M $2.364M
YoY Change -211.32% -59.51% -81.9%
Income Tax $0.00 $0.00 $280.0K
% Of Pretax Income 0.0% 0.0% 11.84%
Net Earnings $5.486M $5.522M $2.084M
YoY Change -211.32% -59.51% -84.04%
Net Earnings / Revenue 26.2% 27.51% 9.19%
Basic Earnings Per Share $0.08 $0.08 -$0.30
Diluted Earnings Per Share $0.08 $0.08 -$0.30
COMMON SHARES
Basic Shares Outstanding 8.935M 8.888M 9.097M
Diluted Shares Outstanding 8.759M 8.914M 9.097M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.97M $34.87M $79.56M
YoY Change -44.55% -61.6% 12.06%
Cash & Equivalents $60.97M $34.87M $79.56M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $70.60M $42.03M $85.84M
YoY Change -39.47% -57.14% 9.49%
LONG-TERM ASSETS
Property, Plant & Equipment $135.1M $169.8M $64.70M
YoY Change 248.34% 334.14% 65.9%
Goodwill
YoY Change
Intangibles $9.131M $12.17M
YoY Change 200.26%
Long-Term Investments $1.548M $1.548M $1.548M
YoY Change -94.17% -98.41% -92.66%
Other Assets $69.24M $43.02M $23.39M
YoY Change 113.65% 185.61% -45.48%
Total Long-Term Assets $2.356B $2.314B $2.001B
YoY Change 21.11% 34.75% 26.82%
TOTAL ASSETS
Total Short-Term Assets $70.60M $42.03M $85.84M
Total Long-Term Assets $2.356B $2.314B $2.001B
Total Assets $2.426B $2.356B $2.087B
YoY Change 17.69% 29.79% 26.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.45M $10.84M $8.182M
YoY Change 162.08% 248.49% 147.94%
Accrued Expenses $47.05M $52.37M $6.112M
YoY Change 673.7% 452.51% 3.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $61.42M $67.14M $18.22M
YoY Change 324.85% 325.15% 59.82%
LONG-TERM LIABILITIES
Long-Term Debt $1.914B $1.842B $1.626B
YoY Change 19.46% 36.9% 24.37%
Other Long-Term Liabilities $3.025M $0.00 $0.00
YoY Change 112.73% -100.0% -100.0%
Total Long-Term Liabilities $1.917B $1.842B $1.626B
YoY Change 19.54% 36.76% 24.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $61.42M $67.14M $18.22M
Total Long-Term Liabilities $1.917B $1.842B $1.626B
Total Liabilities $1.979B $1.909B $1.644B
YoY Change 22.27% 40.1% 24.52%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $9.000K $9.000K
YoY Change -100.0% -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $442.5M $442.3M $442.7M
YoY Change
Total Liabilities & Shareholders Equity $2.426B $2.356B $2.087B
YoY Change 17.69% 29.79% 26.0%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $5.486M $5.522M $2.084M
YoY Change -211.32% -59.51% -84.04%
Depreciation, Depletion And Amortization $1.727M $1.856M $3.508M
YoY Change -43.43% -71.4% 46.17%
Cash From Operating Activities $5.285M $12.16M $1.554M
YoY Change 185.68% -14.01% -83.62%
INVESTING ACTIVITIES
Capital Expenditures -$3.264M -$11.00K -$9.000K
YoY Change 4700.0% -89.81%
Acquisitions
YoY Change
Other Investing Activities -$49.32M -$248.6M $662.0K
YoY Change -76.44% 59.31% -98.65%
Cash From Investing Activities -$52.58M -$248.6M $653.0K
YoY Change -74.89% 59.21% -98.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.885M
YoY Change -59.19%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 64.01M 211.4M -200.8M
YoY Change -73.78% 57.78% 1504.05%
NET CHANGE
Cash From Operating Activities 5.285M 12.16M 1.554M
Cash From Investing Activities -52.58M -248.6M 653.0K
Cash From Financing Activities 64.01M 211.4M -200.8M
Net Change In Cash 16.71M -25.06M 2.207M
YoY Change -54.27% 211.94% -95.21%
FREE CASH FLOW
Cash From Operating Activities $5.285M $12.16M $1.554M
Capital Expenditures -$3.264M -$11.00K -$9.000K
Free Cash Flow $8.549M $12.17M $1.563M
YoY Change 345.72% -14.58% -83.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.333
acr Investment In Real Estate Building Useful Life
InvestmentInRealEstateBuildingUsefulLife
P35Y
acr Investment In Real Estate Building Improvements Useful Life
InvestmentInRealEstateBuildingImprovementsUsefulLife
P8Y
acr Investment In Real Estate Site Improvement Useful Life
InvestmentInRealEstateSiteImprovementUsefulLife
P10Y
acr Investment In Real Estate Tenant Improvements Useful Life
InvestmentInRealEstateTenantImprovementsUsefulLife
P180D
acr Investment In Real Estate Fixtures Useful Life
InvestmentInRealEstateFixturesUsefulLife
P3Y
acr Investment In Real Estate Right Of Use Asset Useful Life
InvestmentInRealEstateRightOfUseAssetUsefulLife
P7Y
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P90D
acr Lease Liabilities Estimated Useful Lives
LeaseLiabilitiesEstimatedUsefulLives
P7Y
CY2022Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2021Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2022Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2021Q2 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
225000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
447326000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q2 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
141666666
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
41666666
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q2 us-gaap Liabilities
Liabilities
1909100000
CY2021Q4 acr Assets Acquired Cost
AssetsAcquiredCost
89701000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2021Q4 acr Assets Acquired Accumulated Depreciation And Amortization
AssetsAcquiredAccumulatedDepreciationAndAmortization
3161000
CY2021Q4 acr Assets Acquired
AssetsAcquired
86540000
CY2022Q2 acr Liabilities Assumed Cost
LiabilitiesAssumedCost
64709000
CY2021Q4 acr Assets Acquired And Liabilities Assumed Cost
AssetsAcquiredAndLiabilitiesAssumedCost
86341000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
175000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
219000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
973000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
434000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
175000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
219000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
513000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1312000
CY2022Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
5522000
CY2021Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
13639000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
7886000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
26695000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
280000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.06
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9711940
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8992142
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9952254
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8992142
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9961211
CY2021Q2 us-gaap Profit Loss
ProfitLoss
13639000
us-gaap Profit Loss
ProfitLoss
7606000
us-gaap Profit Loss
ProfitLoss
26695000
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-461000
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-462000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
461000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
462000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
917000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5983000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
14101000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
8523000
CY2022Q2 acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
4856000
CY2021Q4 acr Assets Acquired And Liabilities Assumed Net
AssetsAcquiredAndLiabilitiesAssumedNet
83311000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10533000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1164000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
448195000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
37000
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3885000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
744000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
2084000
CY2022Q1 acr Distributions And Accrual Of Cumulative Preferred Stock Dividends
DistributionsAndAccrualOfCumulativePreferredStockDividends
4855000
CY2022Q1 acr Amortization Of Terminated Derivatives
AmortizationOfTerminatedDerivatives
456000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
442702000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
33000
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2497000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
991000
CY2022Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
5036000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
5522000
CY2022Q2 acr Distributions And Accrual Of Cumulative Preferred Stock Dividends
DistributionsAndAccrualOfCumulativePreferredStockDividends
4856000
CY2022Q2 acr Amortization Of Terminated Derivatives
AmortizationOfTerminatedDerivatives
461000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
447326000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
334382000
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
9519000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
13056000
CY2021Q1 acr Distributions And Accrual Of Cumulative Preferred Stock Dividends
DistributionsAndAccrualOfCumulativePreferredStockDividends
2588000
CY2021Q1 acr Amortization Of Terminated Derivatives
AmortizationOfTerminatedDerivatives
456000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
335806000
CY2021Q2 acr Adjustments To Additional Paid In Capital Proceeds From Issuance Of Preferred Stock
AdjustmentsToAdditionalPaidInCapitalProceedsFromIssuanceOfPreferredStock
115000000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
4235000
CY2021Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
4317000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
171000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
13639000
CY2021Q2 acr Distributions And Accrual Of Cumulative Preferred Stock Dividends
DistributionsAndAccrualOfCumulativePreferredStockDividends
3568000
CY2021Q2 acr Amortization Of Terminated Derivatives
AmortizationOfTerminatedDerivatives
462000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
452958000
us-gaap Profit Loss
ProfitLoss
7606000
us-gaap Profit Loss
ProfitLoss
26695000
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-1278000
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-15984000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
5364000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
8890000
acr Share Based Compensation Nonemployee And Directors
ShareBasedCompensationNonemployeeAndDirectors
1735000
acr Share Based Compensation Nonemployee And Directors
ShareBasedCompensationNonemployeeAndDirectors
190000
us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
878000
acr Gains Losses On Extinguishment Of Debt Excluding Incurred On Cash Payments
GainsLossesOnExtinguishmentOfDebtExcludingIncurredOnCashPayments
-460000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
5522000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
13639000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
170000
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-4731000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13717000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23644000
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
392121000
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
563801000
us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
216368000
us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
453794000
us-gaap Payments To Acquire Real Estate Held For Investment
PaymentsToAcquireRealEstateHeldForInvestment
72279000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2958000
us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
125000
us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
125000
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
20000
us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
108000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-247927000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
70000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-107032000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6382000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
13836000
us-gaap Profit Loss
ProfitLoss
7606000
us-gaap Profit Loss
ProfitLoss
26695000
CY2022Q2 acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
4856000
CY2021Q2 acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
3568000
acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
9711000
acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
6156000
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-24000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-24000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
690000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10071000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2081000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20539000
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.333
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8930130
CY2022Q2 us-gaap Minority Interest
MinorityInterest
5012000
CY2021Q1 acr Fractional Shares Issued In Connection With Reverse Stock Split
FractionalSharesIssuedInConnectionWithReverseStockSplit
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4235000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
-70000
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
110765000
acr Proceeds From Issuance Of Securitization Of Notes Payable
ProceedsFromIssuanceOfSecuritizationOfNotesPayable
675223000
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
30025000
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
58846000
acr Proceeds From Warehouse Financing Facilities And Repurchase Agreements
ProceedsFromWarehouseFinancingFacilitiesAndRepurchaseAgreements
298882000
acr Proceeds From Warehouse Financing Facilities And Repurchase Agreements
ProceedsFromWarehouseFinancingFacilitiesAndRepurchaseAgreements
334432000
acr Proceeds From Mortgage Payable
ProceedsFromMortgagePayable
18710000
acr Payments Of Commercial Real Estate Notes Payable
PaymentsOfCommercialRealEstateNotesPayable
237189000
acr Payments Of Commercial Real Estate Notes Payable
PaymentsOfCommercialRealEstateNotesPayable
659709000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
10150000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
87831000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
39839000
acr Repayments Of Warehouse Financing Facilities And Repurchase Agreements
RepaymentsOfWarehouseFinancingFacilitiesAndRepurchaseAgreements
38150000
acr Repayments Of Warehouse Financing Facilities And Repurchase Agreements
RepaymentsOfWarehouseFinancingFacilitiesAndRepurchaseAgreements
284890000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
646000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6370000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
5036000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
9711000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5175000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10516000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
121455000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-223694000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
38067000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
283931000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67741000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60237000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105808000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;text-indent:7.56%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and within the period of financial results. Actual results could differ from those estimates. Estimates affecting the accompanying consolidated financial statements include, but are not limited to, the net realizable and fair values of the Company’s investments and derivatives, the estimated useful lives used to calculate depreciation, the expected lives over which to amortize premiums and accrete discounts, reversals of or provisions for expected credit losses and the disclosure of contingent liabilities.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;text-indent:7.56%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The coronavirus (“COVID-19”) pandemic continues to plague countries throughout the globe as virus variants have emerged. Many countries responded to the initial outbreak in late 2019 by instituting quarantines, restricting travel and limiting operations of non-essential offices and retail centers, which resulted in the closure or remote operation of non-essential businesses, increased rates of unemployment and market disruption in connection with the economic uncertainty. While the U.S. and most countries around the world have eased restrictions and financial markets have stabilized to some degree in connection with the development and distribution of vaccines and other effective COVID-19 treatments, the pandemic continues to cause uncertainty on the U.S. and global economies, generally, and the CRE business, specifically. Estimates and assumptions as of June 30, 2022, are inherently less certain than they would </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">be absent the current and potential impacts of COVID-19, particularly the reinstatement of restrictions placed on businesses. The Company believes the estimates and assumptions underlying the consolidated financial statements are reasonable and supportable based on the information available at </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 30, 2022</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Actual results may ultimately differ from those estimates.</span></p>
CY2022Q2 acr Cash Balance In Excess Of Federal Deposit Insurance Limit Amount
CashBalanceInExcessOfFederalDepositInsuranceLimitAmount
31200000
CY2021Q4 acr Cash Balance In Excess Of Federal Deposit Insurance Limit Amount
CashBalanceInExcessOfFederalDepositInsuranceLimitAmount
33300000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34870000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90805000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
25367000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
15003000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60237000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105808000
CY2022Q2 acr Liability Assumed Accumulated Depreciation And Amortization
LiabilityAssumedAccumulatedDepreciationAndAmortization
320000
CY2022Q2 acr Liabilities Assumed Book Value
LiabilitiesAssumedBookValue
64389000
CY2021Q4 acr Liabilities Assumed Cost
LiabilitiesAssumedCost
3360000
CY2022Q2 acr Operating Loss Carryforwards Valuation Allowance Tax Expense Impact
OperatingLossCarryforwardsValuationAllowanceTaxExpenseImpact
21600000
CY2021Q4 acr Liability Assumed Accumulated Depreciation And Amortization
LiabilityAssumedAccumulatedDepreciationAndAmortization
131000
CY2021Q4 acr Liabilities Assumed Book Value
LiabilitiesAssumedBookValue
3229000
CY2022Q2 acr Assets Acquired And Liabilities Assumed Cost
AssetsAcquiredAndLiabilitiesAssumedCost
140830000
CY2022Q2 acr Assets Acquired And Liabilities Assumed Net
AssetsAcquiredAndLiabilitiesAssumedNet
134855000
us-gaap Interest Paid Net
InterestPaidNet
24736000
us-gaap Interest Paid Net
InterestPaidNet
20132000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
180000
acr Receipt Of Right Of Use Assets Noncash
ReceiptOfRightOfUseAssetsNoncash
-479000
acr Execution Of Operating Lease Noncash
ExecutionOfOperatingLeaseNoncash
479000
CY2022Q2 acr Principal Paydowns Receivable
PrincipalPaydownsReceivable
0
CY2021Q4 acr Principal Paydowns Receivable
PrincipalPaydownsReceivable
14900000
CY2021Q4 acr Number Of Defaulted Additional Loans
NumberOfDefaultedAdditionalLoans
2
CY2021 acr Financing Receivable Repayment Period Of Defaulted Additional Loans
FinancingReceivableRepaymentPeriodOfDefaultedAdditionalLoans
2022-01
CY2022Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
2074689000
CY2022Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1882551000
CY2021Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
19916000
CY2022Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
43800000
CY2021Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
30400000
CY2022Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
0
CY2021Q2 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
0
CY2022Q2 acr Assets Acquired Cost
AssetsAcquiredCost
205539000
CY2022Q2 acr Assets Acquired Accumulated Depreciation And Amortization
AssetsAcquiredAccumulatedDepreciationAndAmortization
6295000
CY2022Q2 acr Assets Acquired
AssetsAcquired
199244000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
437000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
94000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
188000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2400000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2000000.0
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1400000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1300000
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1200000
CY2022Q2 acr Non Acquired Operating Lease Right Of Use Asset
NonAcquiredOperatingLeaseRightOfUseAsset
419000
CY2021Q4 acr Non Acquired Operating Lease Right Of Use Asset
NonAcquiredOperatingLeaseRightOfUseAsset
443000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
454000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
477000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y1M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M6D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1065
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1065
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
24000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
25000
us-gaap Operating Lease Cost
OperatingLeaseCost
48000
us-gaap Operating Lease Cost
OperatingLeaseCost
25000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
24000
us-gaap Operating Lease Payments
OperatingLeasePayments
47000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
97000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
454000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y6M
CY2022Q2 us-gaap Profit Loss
ProfitLoss
5522000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
13639000
us-gaap Profit Loss
ProfitLoss
7606000
us-gaap Profit Loss
ProfitLoss
26695000
CY2022Q2 acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
4856000
CY2021Q2 acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
3568000
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1862341000
CY2022Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
20376000
CY2022Q2 us-gaap Notes Payable
NotesPayable
1841965000
CY2022Q2 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0358
acr Debt Instrument Maturity Date Free Form
DebtInstrumentMaturityDateFreeForm
P10Y8M12D
CY2022Q2 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
2139259000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1840052000
CY2021Q4 us-gaap Notes Payable
NotesPayable
1814424000
CY2021Q4 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0244
CY2021 acr Debt Instrument Maturity Date Free Form
DebtInstrumentMaturityDateFreeForm
P12Y8M12D
CY2021Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
2149085000
CY2022Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
363291000
CY2022Q2 us-gaap Securities Loaned Fair Value Of Collateral
SecuritiesLoanedFairValueOfCollateral
636616000
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
63339000
CY2021Q4 us-gaap Securities Loaned Fair Value Of Collateral
SecuritiesLoanedFairValueOfCollateral
272818000
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
1862341000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
48175000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
331810000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
18710000
CY2022Q2 acr Long Term Debt Maturing In Year Four And After
LongTermDebtMaturingInYearFourAndAfter
1463646000
acr Common Shares Repurchased Cost
CommonSharesRepurchasedCost
6400000
acr Common Shares Repurchased Cost
CommonSharesRepurchasedCost
13800000
acr Common Shares Repurchased
CommonSharesRepurchased
552282
acr Common Shares Repurchased
CommonSharesRepurchased
1018453
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
6300000
acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
9711000
acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
6156000
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-24000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-24000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
690000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10071000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2081000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20539000
CY2022Q2 acr Weighted Average Number Of Common Shares Outstanding Basic
WeightedAverageNumberOfCommonSharesOutstandingBasic
8421800
CY2021Q2 acr Weighted Average Number Of Common Shares Outstanding Basic
WeightedAverageNumberOfCommonSharesOutstandingBasic
9245279
acr Weighted Average Number Of Common Shares Outstanding Basic
WeightedAverageNumberOfCommonSharesOutstandingBasic
8525481
acr Weighted Average Number Of Common Shares Outstanding Basic
WeightedAverageNumberOfCommonSharesOutstandingBasic
9485593
CY2022Q2 acr Weighted Average Number Of Warrants Outstanding
WeightedAverageNumberOfWarrantsOutstanding
466661
CY2021Q2 acr Weighted Average Number Of Warrants Outstanding
WeightedAverageNumberOfWarrantsOutstanding
466661
acr Weighted Average Number Of Warrants Outstanding
WeightedAverageNumberOfWarrantsOutstanding
466661
acr Weighted Average Number Of Warrants Outstanding
WeightedAverageNumberOfWarrantsOutstanding
466661
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8888461
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9711940
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8992142
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9952254
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
25711
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
8669
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
8957
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8914172
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9720609
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8992142
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9961211
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.06
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.06
acr Reit Required Taxable Income Distribution Percentage
REITRequiredTaxableIncomeDistributionPercentage
0.90
acr Reit Taxable Income Distribution For Exempt Federal Income Taxes Percentage
REITTaxableIncomeDistributionForExemptFederalIncomeTaxesPercentage
1
CY2022Q2 us-gaap Securities Sold Under Agreements To Repurchase Gross
SecuritiesSoldUnderAgreementsToRepurchaseGross
328402000
CY2022Q2 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0
CY2022Q2 acr Securities Sold Under Agreements To Repurchase Amount Not Offset Against Collateral
SecuritiesSoldUnderAgreementsToRepurchaseAmountNotOffsetAgainstCollateral
328402000
CY2022Q2 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
328402000
CY2022Q2 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
0
CY2022Q2 us-gaap Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase Gross
SecuritiesSoldUnderAgreementsToRepurchaseGross
66771000
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0
CY2021Q4 acr Securities Sold Under Agreements To Repurchase Amount Not Offset Against Collateral
SecuritiesSoldUnderAgreementsToRepurchaseAmountNotOffsetAgainstCollateral
66771000
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
66771000
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
0
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0
CY2022Q2 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
434700000
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
102000000.0
CY2022Q2 us-gaap Litigation Reserve
LitigationReserve
0
CY2021Q4 us-gaap Litigation Reserve
LitigationReserve
0
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
9000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1175146000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7210000
CY2022Q2 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
725641000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
442314000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
5522000
CY2021Q2 acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
3568000
acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
9711000
acr Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
6156000
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8888461
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-917000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-918000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
918000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
27613000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1151000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
41666666
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8930130
CY2022Q2 acr Common Stock Restricted Shares
CommonStockRestrictedShares
583333
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2356426000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21457000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
99000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
99000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
102000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
104000
CY2022Q2 acr Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
170000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
671000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
217000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8914172
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9720609
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.06
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
25628000

Files In Submission

Name View Source Status
0001564590-22-028497-index-headers.html Edgar Link pending
0001564590-22-028497-index.html Edgar Link pending
0001564590-22-028497.txt Edgar Link pending
0001564590-22-028497-xbrl.zip Edgar Link pending
acr-10q_20220630.htm Edgar Link pending
acr-20220630.xsd Edgar Link pending
acr-ex311_10.htm Edgar Link pending
acr-ex312_6.htm Edgar Link pending
acr-ex321_13.htm Edgar Link pending
acr-ex322_16.htm Edgar Link pending
acr-ex991_147.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gi5saw3r0rno000001.jpg Edgar Link pending
gi5saw3r0rno000002.jpg Edgar Link pending
gi5saw3r0rno000003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
acr-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
acr-20220630_def.xml Edgar Link unprocessable
acr-10q_20220630_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
acr-20220630_cal.xml Edgar Link unprocessable
acr-20220630_lab.xml Edgar Link unprocessable